Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 5—May 2014


Shigella spp. with Reduced Azithromycin Susceptibility, Quebec, Canada, 2012–2013

Christiane GaudreauComments to Author , Sapha Barkati, Jean-Michel Leduc, Pierre A. Pilon, Julie Favreau, and Sadjia Bekal
Author affiliations: Centre Hospitalier de l’Université de Montréal–Hôpital Saint-Luc, Montreal, Quebec, Canada (C. Gaudreau, S. Barkati, J.-M. Leduc, J. Favreau); Université de Montréal, Montreal (C. Gaudreau, S. Barkati, J.-M. Leduc, P.A. Pilon, S. Bekal); Agence de la Santé et des Services Sociaux de Montréal-Santé Publique, Montreal (P.A. Pilon); Laboratoire de Santé Publique du Québec/Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada (C. Gaudreau, S. Bekal)

Main Article

Table 1

Azithromycin susceptibility of 26 Shigella sppisolates from 25 patients, Centre Hospitalier de l’Université de Montréal– Hôpital Saint-Luc, Montreal, Quebec, Canada, January 2012–April 2013*

Azithromycin susceptibility No. infections acquired locally No. infections acquired abroad
Reduced 10 0
Susceptible 7 9

*p = 0.0039. All patients with locally-acquired Shigella and 3 patients with Shigella infections acquired abroad were men. One patient was infected successively with 2 Shigella species with reduced azithromycin susceptibility. For all patients infected with Shigella spp. with decreased azithromycin susceptibility, the strains were isolated from feces and none from blood.

Main Article